Nosocomial infections, caused by acinetobacter neonatology care unit of children's hospital in Casablanca;Infections nosocomiales a acinetobacter experience du service de neonatologie de Casablanca

Tunisie Medicale

Volumn 81, Issue 2, 2003, Pages 121-125

  Nejjari, Noureddine ^a   Zerhouni, Farah ^a   Bouharrou, Abdelhaq ^a   Habzi, Abderrahime ^a   Najdi, Toufiq ^a   Lahbabi Mohmed, S ^a   Benomar, Said ^a  

^a Hopital d'Enfants   (Morocco)

Author keywords

Acinetobacter; Antibioresistance; Newborn; Nosocomial infection; Prevention

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; CEFOTAXIME; CEFTAZIDIME; CEPHALOSPORIN; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; NETILMICIN; PENICILLIN G;

ACINETOBACTER; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INCIDENCE; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; MENINGITIS; MORTALITY; NEWBORN; NEWBORN INTENSIVE CARE; PNEUMONIA; RETROSPECTIVE STUDY; SEPTICEMIA; SEX RATIO; BACTERIAL INFECTION; COMPARATIVE STUDY; CROSS INFECTION; DRUG EFFECT; ISOLATION AND PURIFICATION; MICROBIOLOGY; MOROCCO; MULTIDRUG RESISTANCE;

ACINETOBACTER; ACINETOBACTER INFECTIONS; AMIKACIN; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; IMIPENEM; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; MOROCCO; RETROSPECTIVE STUDIES;

EID: 0037309505     PISSN: 00414131     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. -Ford-Jones EL, Mindoref CM, Langley JM et al. Epidemiological study of 4684 hospital-acquired infections in paediatric patients. Pediatr Infect Dis J 1989; 8: 668-75.
2. -Jarvis WR. Epidemiology of nosocomial infections in paediatric patients. Pediatr Infect Dis J 1987; 6: 344-51.
3. -Bergogne-B E. Les infections nosocomiales: Nouveaux agents, incidence, prevention. Presse Med 1995; 24: 89-97.
4. -Maurin M, Musso D, Charrel R et al. Résistance aux antibiotiques des bactéries hospitalières(bacilles à Gram négatif aérobies). Situation 1992 à Marseille. Méd Mal Infect. 1995; 25,508-14.
5. -Nejjari N, Benomar S, Lahbabi MS. Les infections nosocomiales en réanimation néonotale et pédiatrique. Intérêt de la ciprofloxacine. Arch Pédiatr 2000; 7: 1268-73.
6. -Joly-Guillou ML, Bergogne BE, Vieu JF. Epidemiologie et résistance aux antibiotiques des Acinetobacter en milieu hospitalier. Presse Med, 1990; 19: 357-61.
7. -Schefftel JM, Weber M. Résistance à 16 antibiotiques de 3876 bacilles à Gram négatif aérobies isolés dans 39 centres de soins intensifs en France. Méd Mal Infect. 1994; 24: 255-62.
8. -Duval J, Soussy CJ, Koumar B, Juliet C, Deforges L. Evolution des bactérieshospitalières. Pathol Biolog 1982; 30: 405-14.
9. -Scerpella EG, Wanger AR, Armittige L, Auderlini P, Ericson CD. Nosocomial outbreak caused by an multiresistant clone of Acinetobacter Bournanii. Infect Control Hosp Epidemiol. 1995; 16(2): 92-7.
10. -Horrevorts A, Bergman K, Kolle L, Tjernberg I, Dijkshoorn L. Clinical and investigations of Acinetobacter in neonatal ICU. J. Clin Microbial. 1995; 33(6): 1567-72.
11. -Cisneros JM, Reyes MJ, Pachon J et al. Bacteraemia due to Acinetobacter Baumanii: Epidemiology clinical findings and prognostic features. Clin Infect Dis. 1996; 22(6): 1026-32.
12. -Mulin B, Talon D, Viel JF et al: Risk factors for nosocomial colonization with multi-resistant Acinetobacter Baumanii. Eur J Clin Microbiol Infect Dis. 1995; 14(7): 569-76.
13. -Van Saene HKF, Stoutenbeek CP, Stoller JK, Selective decontamination of the digestive tract in the intensive care unit: current status and future prospects. Crit Care Med 1992; 20: 691-703.
14. -Godineau-G. N, Lesage D, Tessier F, Kollia D, Dagnet G. L. Acinetobacter Calcoaceticus varieté anitratus, étude de la sensibilité aux antibiotiques de 65 souches hospitalières. Med. Mal. Inf. 1988, 2 bis, 124-9.
15. -Thabaut A, Bebear C, Boucot I, Chiche D. Evolution de la sensibilité des BGN à la céftazidime et à trois autres betalactamines en milieu hospitalier de 1989 à 1993. Med Mal Infect 1995; 25: 6-19.
16. -Denis F. Bactériologie des infections nosocomiales. Agressologie, 1987; 28; 11: 1121-2.
17. -Bergogne BE. Activité bactérienne in vitro: Acinetobacter Baumanii. Lettre de l'infectiologie: Tame X 1995; 19-29.
18. -Muller SC, Lesquoy JB, Perez E et al. Infections nosocomiales à Acinetobacter: Epidemiologie et difficultés thérapeutiques. Presse Med 1989; 18; 3: 107-10.
19. -Seifret H, Strate A, Schulze A, Pulverer G. Bacterimia due to Acinetobacter species other than Acinetobacter baumanii. Infection München 1994; 22: 6: 379-83.
20. -Marques MB, Brooking ES, Moser SA, Sonke B, Waites KB. Comparative in vitro antimicrobial susceptibilities of nosocomial isolates of Acinetobacter Baumanii and synergetic activities of nine antimicrobial combinations. Antimicrob Agent and chemother. 1997; 41 (5): 881-85.